Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia

Eastern Mediterranean Health Journal

Volumn 12, Issue 1-2, 2006, Pages 178-187

  Mahmoud, Randa A K ^a   Raouf, M Abdel ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOSTATIN; VASCULOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANT WOMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; DIASTOLE; DISCRIMINANT ANALYSIS; EGYPT; ENDOSTATINS; FEMALE; GESTATIONAL AGE; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROGNOSIS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SYSTOLE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33748439268     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. VanWijk M et al. Vascular function in pre-eclampsia. Cardiovascular research, 2000, 47(1):38-48.
2. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocrine reviews, 2004, 25(4):581-611.
3. Torry D, Hinrichs M, Torry R. Determinants of placental vascularity. American journal of reproductive immunology, 2004, 51 (4):257-68.
4. Levine R et al. Circulating angiogenic factors and the risk of pre-eclampsia. New England journal of medicine, 2004, 350(7):672-83.
5. Hanai J et al. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. Journal of biological chemistry, 2002, 277(19):164-9.
6. Moulton K et al. Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation, 2004, 110(10):1330-6.
7. Hirtenlehner K et al. Elevated serum concentrations of the angiogenesis inhibitor endostatin in pre-eclamptic women. Journal of the Society for Gynecological Investigation, 2003, 10:412-7.
8. American College of Obstetricians Gynecologists. ACOG practice bulletin. Diagnosis and management of pre-eclampsia and eclampsia. International journal of gynaecology and obstetrics, 2002, 77(1): 67-75.
9. Svedas E et al. Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women. American journal of obstetrics and gynecology, 2003, 188:168-76.
10. Kupferminc M et al. Vascular endothelial growth factor is increased in patients with pre-eclampsia. American journal of reproductive immunology, 1997, 38:302-6.
11. El-Salahy E et al. New scope in angiogenesis: Role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females. Clinical biochemistry, 2001, 34:323-9.
12. Hunter A et al. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension, 2000, 36:965-9.
13. Bielecki D et al. Niektore czynniki wzrostu w ciazy powiklanej preeklampsja. [Growth factors in pregnancy complications with pre-eclampsia.] Ginekologia polska, 2002, 73(5):422-9.
14. Livingston J et al. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe pre-eclampsia. American journal of obstetrics and gynecology, 2000, 183(6): 1554-7.
15. Reuvekamp, A. et al. Selective deficit of angiogenic growth factors characterizes pregnancies complicated by pre-eclampsia. British journal of obstetrics and gynaecology, 1999, 106:1019-22.
16. Anthony F et al. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Annals of clinical biochemistry, 1997, 34:276-80.
17. Roberts D et al. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signalling during blood vessel formation. American journal of pathology, 2004, 164:1531-5.
18. Maynard S et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension and proteinuria in pre-eclampsia. Journal of clinical investigation, 2003, 111:649-58.
19. Zhou Y et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe pre-eclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. American journal of pathology, 2002, 160:1405-23.
20. Bono P, Teerenhovi L, Joensuu H. Elevated serum endostatin is associated with poor outcome in patients with non-hodgkin lymphoma. Cancer, 2003, 97: 2767-75.
21. Ferreras M et al. Generation and degradation of human endostatin proteins by various proteinases. FEBS letters, 2000, 486:247-51.
22. Narumiya H et al. Matrix metalloproteinase-2 is elevated in the plasma of women with pre-eclampsia. Hypertension in pregnancy, 2001, 20(2):185-94.
23. Ergun S et al. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis, 2001, 4: 193-206.
24. Kim Y et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. Journal of biological chemistry, 2002, 277(31):27872-9.
25. Urbich C et al. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-argiogenic effects of endostatin. FASEB journal, 2002, 16(7):706-8.
26. Wickstrom S, Alitalo K, Keski-Oja J. Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer research, 2002, 62(19):5580-9.
27. Goodwin A, D'Amore P. Wnt signaling in the vasculature. Angiogenesis, 2002, 5(1-2):1-9.
28. Abdollahi A et al. Endostatin's antiangiogenic signaling network. Molecular cell, 2004, 13(5):649-63.
29. Eremina V, Quaggin S. The role of VEGF-A in glomerular development and function. Current opinion in nephrology and hypertension, 2004, 13(1):9-15.
30. Dhar D et al. Serum endostatin predicts tumour vascularity in hepatocellular carcinoma. Cancer, 2002, 95:2188-95.
31. Liu M, He Y, Peng D. Expression of vascular endothelial growth factor and endostatin in peritoneal fluid of patients with endometriosis. Di yi jun yi da xue xue bao, 2004, 24(1):69-71.